Bachem Holding AG is a CDMO of peptides based in Switzerland / USA. Direct manufacturer. Founded 1971. Key products include Catalog Peptides, Custom Peptide Synthesis.
Listing reviewed September 2026.
Swiss public CDMO (BANB.SW). Founded 1971, headquartered in Bubendorf, Switzerland. Operates 6 GMP facilities across Switzerland, USA, and UK. Produces peptides and oligonucleotides for pharma/biotech. Leading supplier of commercial peptide APIs. Offers global door-to-door logistics for research and commercial clients.
Directory assessment: Bachem Holding AG is listed as a CDMO in the peptide supply chain, serving Global markets from Switzerland / USA. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 3 sources for reference. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.